Text Size

Quality of Life Following Radical Prostatectomy

This study is currently recruiting participants.
Verified June 2013 by Stanford University
Sponsor:
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT00373308
First received: September 6, 2006
Last updated: June 12, 2013
Last verified: June 2013
History of Changes
  Purpose

This study will utilize the Expanded Prostate Cancer Index Composite questionnaire to learn what impact the surgery has upon the participant's sense of health, sexual and urinary quality of life.


Condition
Prostatic Neoplasms
Prostate Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Quality of Life Following Radical Prostatectomy

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Stanford University:

Primary Outcome Measures:
  • urinary and bowel habits [ Time Frame: before and after surgery ] [ Designated as safety issue: No ]
  • sexual and hormonal index as self-reported in the questionnaires [ Time Frame: before and after surgery ] [ Designated as safety issue: No ]

Estimated Enrollment: 200
Study Start Date: September 2002
Estimated Study Completion Date: December 2017
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Detailed Description:

To define impact on quality of life issues for patients undergoing radical prostatectomy. This study will distribute a questionnaire to patients who are being scheduled for radical prostatectomy, both before and after surgery, to assess the impact on quality of life issues. This will provide important information regarding the temporal return of issues pertaining to quality of life.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients scheduled to undergo radical prostatectomy at Stanford

Criteria

Inclusion Criteria:

- Patients scheduled to undergo radical prostatectomy at Stanford

Exclusion Criteria:

- Patients treated with neoadjuvant or adjuvant hormonal therapy or radiation therapy

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00373308

Contacts
Contact: Ida Bezabeh 650-725-8057 ibezabeh@stanford.edu

Locations
United States, California
Stanford University School of Medicine Recruiting
Stanford, California, United States, 94305
Contact: Ida Bezabeh, MS     650-725-8057     ibezabeh@stanford.edu    
Principal Investigator: Benjamin I Chung            
Sub-Investigator: James D Brooks            
Sub-Investigator: Harcharan Gill            
Sub-Investigator: Mark Gonzalgo            
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: Benjamin I Chung Stanford University
  More Information

No publications provided

Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT00373308     History of Changes
Other Study ID Numbers: PROS0012, 78463, PROS0012
Study First Received: September 6, 2006
Last Updated: June 12, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Stanford University:
Quality of Life

Additional relevant MeSH terms:
Neoplasms
Prostatic Neoplasms
Genital Neoplasms, Male
Urogenital Neoplasms
 Neoplasms by Site
Genital Diseases, Male
Prostatic Diseases

ClinicalTrials.gov processed this record on June 18, 2013